Internet-Administered Smoking Cessation Treatment for Overweight and Obese Smokers
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This project will be a randomized clinical trial testing the efficacy of an
internet-administered smoking cessation treatment for overweight and obese smokers. Research
on internet-administered behavioral treatments for smoking cessation has found that compared
to control treatments (e.g., self-help materials), cessation rates in internet-administered
treatments are significantly higher. Research testing the applicability of these treatments
to overweight and obese individuals has not yet been conducted. Given that a substantial
portion of smokers are also overweight and at elevated cardiovascular risk, there is a need
for directed treatment efforts for this group. The current trial proposes to be the first to
test the effectiveness of internet-administered smoking cessation treatment for overweight
and obese (BMI≥25) smokers. Adult participants will be randomized to receive 12 weeks of
internet-administered treatment consisting of either: a) standard smoking cessation treatment
with general health education, or b) standard smoking cessation treatment with cognitive
behavioral therapy (CBT) for weight concerns. Participants in both conditions will receive
open-label treatment with the 21 mg transdermal nicotine patch.